title: Topographical analysis of sleep spindle activity.
abstract: There is evidence for two types of sleep spindle activity, one with a frequency of about 12 cycles/s (cps) and the other of about 14 cps. Visual examination indicates that both spindle types occur independently, whereby the 12-cps spindles are more pronounced in the frontal and the 14-cps spindles in the parietal region. The purpose of this paper is to provide more information about the exact topography of these patterns. First the occurrence of distinct signals in anterior and posterior brain regions was verified using pattern recognition techniques based on matched filtering. Thus the existence of two distinct sources of activity located in the frontal and parietal region of the brain, respectively, was demonstrated using EEG frequency mapping. Evaluation of sleep recordings showed high stability both in the frequency and location of the presumed spindle generators across sleep. Pharmacological effects of lormetazepam and zopiclone on both spindle types were investigated. Both substances enhanced the sleep spindle activity recorded from the frontal and parietal electrodes, but this increase was more pronounced in the parietal brain region.
authors.affiliation: AFB-Parexel, Arzneimittelforschung, GmbH, Europa Center, Berlin, FRG.
authors.forename: M
authors.initials: M
authors.lastname: Jobert
authors.forename: E
authors.initials: E
authors.lastname: Poiseau
authors.forename: P
authors.initials: P
authors.lastname: Jähnig
authors.forename: H
authors.initials: H
authors.lastname: Schulz
authors.forename: S
authors.initials: S
authors.lastname: Kubicki
mesh_terms: D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents; D053961:Azabicyclo Compounds; D001569:Benzodiazepines; D001931:Brain Mapping / Q000295:instrumentation; D004311:Double-Blind Method; D004569:Electroencephalography / Q000187:drug effects* / Q000295:instrumentation; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D005260:Female; D005625:Frontal Lobe / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008140:Lorazepam / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010296:Parietal Lobe / Q000187:drug effects / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use; D017286:Polysomnography / Q000295:instrumentation; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000503:physiopathology*; D012894:Sleep Stages / Q000187:drug effects / Q000502:physiology*
chemical_list: D014151:Anti-Anxiety Agents; D053961:Azabicyclo Compounds; D006993:Hypnotics and Sedatives; D010879:Piperazines; C515050:zopiclone; D001569:Benzodiazepines; C023842:lormetazepam; D008140:Lorazepam